Clinical trial
Sunitinib in Treating Patients With Advanced Malignant Pleural Mesothelioma
NCT00392444
Study timeline
Study start (unknown)2007-02-01Date precision: month
Registry last updated2014-05-21
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Advanced Malignant Mesotheliomaunresolved
Recurrent Malignant Mesotheliomaunresolved
Interventions
sunitinib malateDRUG · verified · RxNorm: sunitinib malate
Sponsors & collaborators
National Cancer Institute (NCI)lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00392444 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.